Vertex Pharmaceuticals (NQ:VRTX)
Price and Volume
Detailed Quote| Volume | 385 |
| Open | 443.92 |
| Bid (Size) | 439.26 (80) |
| Ask (Size) | 444.90 (40) |
| Prev. Close | 443.92 |
| Today's Range | 443.92 - 443.92 |
| 52wk Range | 362.50 - 510.77 |
| Shares Outstanding | 259,428,394 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
2 Stocks I Plan to Hold for the Next 20 Years ↗
March 27, 2026
Where Will Vertex Pharmaceuticals Be in 1 Year? ↗
March 25, 2026
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗
March 23, 2026
Is CRISPR Therapeutics Stock a Buy Now? ↗
March 20, 2026
My Top 3 Drug Stocks for March 2026 ↗
March 20, 2026
1 Momentum Stock to Research Further and 2 We Ignore
March 16, 2026
Is Vertex Pharmaceuticals Heading to $600? ↗
March 15, 2026
This Stock Just Jumped By 8%: Is It Too Late to Buy? ↗
March 13, 2026
2 Reasons to Watch VRTX and 1 to Stay Cautious
March 13, 2026
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 443.92
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 04/08/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 115.17B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 115B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.